Legend Biotech USA Inc.

Contributing Author

Recent Articles by Legend Biotech USA Inc.

Dec-06	Legend Biotech Highlights New CARVYKTI Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 LEGN GlobeNewswire
Nov-27	Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade LEGN GlobeNewswire
Nov-13	Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia LEGN GlobeNewswire
Nov-12	Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights LEGN GlobeNewswire
Nov-03	Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting LEGN GlobeNewswire
Oct-29	Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results LEGN GlobeNewswire
Aug-26	Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference LEGN GlobeNewswire
Aug-18	Legend Biotech Appoints Carlos Santos as Chief Financial Officer LEGN GlobeNewswire
Aug-11	Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights LEGN GlobeNewswire
Jul-28	Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results LEGN GlobeNewswire
Jun-03	Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI in Multiple Myeloma at 2025 ASCO Annual Meeting LEGN GlobeNewswire
May-22	Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT LEGN GlobeNewswire
May-19	Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting LEGN GlobeNewswire
May-13	Legend Biotech Reports First Quarter 2025 Results and Recent Highlights LEGN GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.